ArticleCancer letters2014

Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activity.

Oliver Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.